{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:38:48Z","timestamp":1787755128629,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery"],"published-print":{"date-parts":[[2018,9,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Revision hip arthroplasty poses several challenges, including the management of perioperative blood loss. Recent studies have validated the use of tranexamic acid in primary total hip arthroplasty, showing reduced blood loss and decreased number of allogenic blood transfusions. The effectiveness of tranexamic acid has not been well studied in the revision hip arthroplasty setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We performed a retrospective review of 1,072 patients who underwent revision hip arthroplasty at our institution from 2008 to 2016. A total of 634 patients met the inclusion criteria, and comparisons were made between 232 consecutive patients without the use of tranexamic acid and 402 consecutive patients with the use of tranexamic acid. Patients were subdivided into 4 groups based on the complexity of revision surgical procedures: (1) major revision, (2) isolated femoral component revision, (3) isolated acetabular component revision, and (4) isolated femoral head and acetabular liner exchange. Within these groups, we compared the demographic data, estimated intraoperative blood loss, perioperative blood units transfused, postoperative hemoglobin drop, and thromboembolic complications between patients receiving either tranexamic acid or no antifibrinolytic therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The primary outcomes of our study (estimated intraoperative blood loss, postoperative hemoglobin drop, and perioperative blood transfusion) were all reduced in patients who received tranexamic acid compared with patients who received no antifibrinolytic therapy. When analyzed on the basis of the complexity of surgical revision, there was a decrease in estimated intraoperative blood loss following tranexamic acid administration in the major revision group (845 compared with 1,095 mL; p &lt; 0.001). The postoperative drop in hemoglobin was lower in the major revision group with tranexamic acid administration (by 8.9 g\/L; p &lt; 0.01) and the isolated acetabular component revision group with tranexamic acid administration (by 11.9 g\/L; p &lt; 0.001). The need for perioperative blood transfusion was reduced across all revisions treated with tranexamic acid (major revision group, 1.79 compared with 3.33 units, p &lt; 0.001; femoral revision only, 0.97 compared with 2.25 units, p &lt; 0.01; acetabular revision only, 0.73 compared with 1.72 units, p &lt; 0.001; and head and liner exchange, 0.15 compared with 0.89 unit, p &lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Based on this study, preoperative administration of intravenous tranexamic acid in revision hip arthroplasty reduces allogenic blood transfusions and perioperative blood loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level III<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.17.01212","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T15:43:10Z","timestamp":1536162190000},"page":"1509-1516","source":"Crossref","is-referenced-by-count":27,"title":["The Effect of Preoperative Administration of Intravenous Tranexamic Acid During Revision Hip Arthroplasty"],"prefix":"10.2106","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-3992","authenticated-orcid":false,"given":"Jonathan","family":"Peck","sequence":"first","affiliation":[{"name":"Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-1983","authenticated-orcid":false,"given":"David M.","family":"Kepecs","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9251-4583","authenticated-orcid":false,"given":"Bill","family":"Mei","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-3017","authenticated-orcid":false,"given":"Oleg A.","family":"Safir","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-7334","authenticated-orcid":false,"given":"David","family":"Backstein","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0830-1134","authenticated-orcid":false,"given":"Allan E.","family":"Gross","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-9043","authenticated-orcid":false,"given":"Paul R.","family":"Kuzyk","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"issue":"6","key":"bib1-20230811","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00590-015-1635-0","article-title":"Comparison of patient quality of life scores and satisfaction after common orthopedic surgical interventions","volume":"25","author":"Lim","year":"2015","journal-title":"Eur J Orthop Surg Traumatol."},{"key":"bib2-20230811","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13018-015-0188-6","article-title":"Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study","volume":"10","author":"Carling","year":"2015","journal-title":"J Orthop Surg Res."},{"issue":"4","key":"bib3-20230811","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1537-2995.2003.00348.x","article-title":"OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe","volume":"43","author":"Rosencher","year":"2003","journal-title":"Transfusion."},{"issue":"10","key":"bib4-20230811","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1537-2995.2010.02697.x","article-title":"Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study","volume":"50","author":"Vuille-Lessard","year":"2010","journal-title":"Transfusion."},{"issue":"6","key":"bib5-20230811","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid: a review of its use in surgery and other indications","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs."},{"issue":"5","key":"bib6-20230811","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1213\/00000539-200011000-00014","article-title":"Tranexamic acid reduces blood loss in total hip replacement surgery","volume":"91","author":"Ekb\u00e4ck","year":"2000","journal-title":"Anesth Analg."},{"issue":"6","key":"bib7-20230811","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1302\/0301-620X.91B6.22393","article-title":"The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement","volume":"91","author":"Rajesparan","year":"2009","journal-title":"J Bone Joint Surg Br."},{"issue":"9734","key":"bib8-20230811","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"CRASH-2 Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet."},{"issue":"4","key":"bib9-20230811","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00015458.2007.11680081","article-title":"Reduction of blood loss with tranexamic acid in primary total hip replacement surgery","volume":"107","author":"Claeys","year":"2007","journal-title":"Acta Chir Belg."},{"issue":"1","key":"bib10-20230811","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3928\/01477447-20091124-30","article-title":"The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia","volume":"33","author":"Kazemi","year":"2010","journal-title":"Orthopedics."},{"issue":"1","key":"bib11-20230811","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1302\/0301-620X.93B1.24984","article-title":"Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement","volume":"93","author":"Sukeik","year":"2011","journal-title":"J Bone Joint Surg Br."},{"issue":"3","key":"bib12-20230811","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/tme.12212","article-title":"The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases","volume":"25","author":"Wei","year":"2015","journal-title":"Transfus Med."},{"issue":"2","key":"bib13-20230811","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.arth.2013.05.026","article-title":"The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty","volume":"29","author":"Wind","year":"2014","journal-title":"J Arthroplasty."},{"key":"bib14-20230811","doi-asserted-by":"crossref","first-page":"g4829","DOI":"10.1136\/bmj.g4829","article-title":"Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety","volume":"349","author":"Poeran","year":"2014","journal-title":"BMJ."},{"issue":"12","key":"bib15-20230811","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5435\/JAAOS-D-14-00223","article-title":"Tranexamic acid in hip and knee arthroplasty","volume":"23","author":"Melvin","year":"2015","journal-title":"J Am Acad Orthop Surg."},{"issue":"6","key":"bib16-20230811","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/acr.22523","article-title":"Direct hospital cost determinants following hip and knee arthroplasty","volume":"67","author":"Peel","year":"2015","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"4","key":"bib17-20230811","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1537-2995.2009.02518.x","article-title":"Activity-based costs of blood transfusions in surgical patients at four hospitals","volume":"50","author":"Shander","year":"2010","journal-title":"Transfusion."},{"issue":"3","key":"bib18-20230811","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/230949901001800305","article-title":"Effects of tranexamic acid on blood loss during total hip arthroplasty","volume":"18","author":"Singh","year":"2010","journal-title":"J Orthop Surg (Hong Kong)."},{"issue":"2","key":"bib19-20230811","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ocl.2016.12.001","article-title":"Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis","volume":"48","author":"Evangelista","year":"2017","journal-title":"Orthop Clin North Am."},{"issue":"23","key":"bib20-20230811","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2106\/JBJS.N.00077","article-title":"Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates","volume":"96","author":"Hart","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib21-20230811","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.arth.2016.08.026","article-title":"Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis","volume":"32","author":"Kim","year":"2017","journal-title":"J Arthroplasty."},{"issue":"4","key":"bib22-20230811","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2106\/JBJS.L.01268","article-title":"Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty","volume":"96","author":"Friedman","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"2","key":"bib23-20230811","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ALN.0b013e3181e08e97","article-title":"Anemia and patient blood management in hip and knee surgery: a systematic review of the literature","volume":"113","author":"Spahn","year":"2010","journal-title":"Anesthesiology."},{"issue":"4","key":"bib24-20230811","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"bib25-20230811","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5301\/HIP.2012.10143","article-title":"The effect of bolus administration of tranexamic acid in revision hip arthroplasty","volume":"22","author":"Kazi","year":"2012","journal-title":"Hip Int."},{"issue":"2","key":"bib26-20230811","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11999-010-1441-2","article-title":"Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty","volume":"469","author":"Noordin","year":"2011","journal-title":"Clin Orthop Relat Res."},{"issue":"9","key":"bib27-20230811","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1302\/0301-620X.88B9.17605","article-title":"Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery?","volume":"88","author":"Phillips","year":"2006","journal-title":"J Bone Joint Surg Br."},{"issue":"11","key":"bib28-20230811","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.arth.2016.03.059","article-title":"The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial","volume":"31","author":"Wu","year":"2016","journal-title":"J Arthroplasty."},{"issue":"12","key":"bib29-20230811","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.arth.2016.05.058","article-title":"Tranexamic acid reduces blood transfusions in revision total hip arthroplasty","volume":"31","author":"Park","year":"2016","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib30-20230811","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/107602960300900207","article-title":"A model for clinical estimation of perioperative hemorrhage","volume":"9","author":"Howe","year":"2003","journal-title":"Clin Appl Thromb Hemost."},{"key":"bib31-20230811","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.blo.0000192033.50316.bf","article-title":"Blood salvage and allogenic transfusion needs in revision hip arthroplasty","volume":"441","author":"Garvin","year":"2005","journal-title":"Clin Orthop Relat Res."},{"issue":"11","key":"bib32-20230811","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2106\/00004623-200311000-00013","article-title":"Efficacy of intraoperative blood collection and reinfusion in revision total hip arthroplasty","volume":"85","author":"Zarin","year":"2003","journal-title":"J Bone Joint Surg Am."},{"issue":"3","key":"bib33-20230811","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00016470510030751","article-title":"Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients","volume":"76","author":"Johansson","year":"2005","journal-title":"Acta Orthop."},{"issue":"10","key":"bib34-20230811","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/trf.13735","article-title":"Red blood cell transfusion: 2016 clinical practice guidelines from AABB","volume":"56","author":"Tobian","year":"2016","journal-title":"Transfusion."},{"issue":"10","key":"bib35-20230811","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/BOT.0000000000000968","article-title":"TXA Study Group. Effect of tranexamic acid on transfusion: a randomized clinical trial in acetabular fracture surgery","volume":"31","author":"Lack","year":"2017","journal-title":"J Orthop Trauma."},{"issue":"4","key":"bib36-20230811","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.arth.2003.12.073","article-title":"Bone bleeding during total hip arthroplasty after administration of tranexamic acid","volume":"19","author":"Garneti","year":"2004","journal-title":"J Arthroplasty."},{"issue":"2","key":"bib37-20230811","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.arth.2014.08.022","article-title":"Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty","volume":"30","author":"Duncan","year":"2015","journal-title":"J Arthroplasty."},{"issue":"3","key":"bib38-20230811","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5582\/ddt.2015.01018","article-title":"Topical administration of tranexamic acid in total hip arthroplasty: a meta-analysis of randomized controlled trials","volume":"9","author":"Xu","year":"2015","journal-title":"Drug Discov Ther."},{"issue":"12","key":"bib39-20230811","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.arth.2014.03.032","article-title":"Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial","volume":"29","author":"Yue","year":"2014","journal-title":"J Arthroplasty."},{"issue":"21","key":"bib40-20230811","doi-asserted-by":"crossref","first-page":"e6916","DOI":"10.1097\/MD.0000000000006916","article-title":"Is combined topical and intravenous tranexamic acid superior to intravenous tranexamic acid alone for controlling blood loss after total hip arthroplasty? A meta-analysis","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltimore)."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201809050-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:37:58Z","timestamp":1787751478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201809050-00010"}},"subtitle":["A Retrospective Study"],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":40,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.17.01212","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]}}}